Cost per day of patency: Understanding the impact of patency and reintervention in a sustainable model of healthcare

Journal of Vascular Surgery

Volumn 48, Issue 6, 2008, Pages 1489-1496

  Stoner, Michael C ^a   deFreitas, Dorian J ^a   Manwaring, Mark M ^a   Carter, Jacqueline J ^a   Parker, Frank M ^a   Powell, C Steven ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLAUDICATION; COMORBIDITY; CONTROLLED STUDY; FEMALE; FEMOROPOPLITEAL BYPASS; HEALTH CARE COST; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVASCULARIZATION;

AGED; ANGIOPLASTY; COST-BENEFIT ANALYSIS; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HOSPITAL COSTS; HUMANS; MALE; MIDDLE AGED; MODELS, ECONOMIC; PERIPHERAL VASCULAR DISEASES; POPLITEAL ARTERY; PROGNOSIS; REOPERATION; RETROSPECTIVE STUDIES; TIME FACTORS; UNITED STATES;

EID: 57949084051     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2008.07.003     Document Type: Article

References (18)

1. Contos B. Vascular centers of excellence - a tactical approach (2007), The Advisory Board Company, Washington (DC)
2. Orszag P.R., and Ellis P. Addressing rising health care costs-a view from the Congressional Budget Office. N Engl J Med 357 (2007) 1885-1887
3. Rutherford R.B., Baker J.D., Ernst C., Johnston K.W., Porter J.M., Ahn S., and Jones D.N. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 26 (1997) 517-538
4. Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., and Fowkes F.G. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 45 Suppl S (2007) S5-S67
5. Stoner M.C., Manwaring M.L., and deFreitas D.J. Amortized vascular cost. http://www.sourceforge.net/projects/amcost Accessed August 18, 2008
6. Janne d'Othee B., Morris M.F., Powell R.J., and Bettmann M.A. Cost determinants of percutaneous and surgical interventions for treatment of intermittent claudication from the perspective of the hospital. Cardiovasc Intervent Radiol 31 (2008) 56-65
7. Jansen R.M., de Vries S.O., Cullen K.A., Donaldson M.C., and Hunink M.G. Cost identification analysis of revascularization procedures on patients with peripheral arterial occlusive disease. J Vasc Surg 28 (1998) 617-623
8. Muradin G.S., and Myriam Hunink M.G. Cost and patency rate targets for the development of endovascular devices to treat femoropopliteal arterial disease. Radiology 218 (2001) 464-469
9. Laurila J., Brommels M., Standertskjold-Nordenstam C.G., Leinonen S., Lepantalo M., Edgren J., and Suramo I.I. Cost-effectiveness of percutaneous transluminal angioplasty (PTA) versus vascular surgery in limb-threatening ischaemia. Int J Angiol 9 (2000) 214-219
10. Kudo T., Chandra F.A., and Ahn S.S. The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: a 10-year experience. J Vasc Surg 41 (2005) 423-435 discussion 435
11. Conrad M.F., Cambria R.P., Stone D.H., Brewster D.C., Kwolek C.J., Watkins M.T., et al. Intermediate results of percutaneous endovascular therapy of femoropopliteal occlusive disease: a contemporary series. J Vasc Surg 44 (2006) 762-769
12. Adam D.J., Beard J.D., Cleveland T., Bell J., Bradbury A.W., Forbes J.F., et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 366 (2005) 1925-1934
13. Hunink M.G., Wong J.B., Donaldson M.C., Meyerovitz M.F., de Vries J., and Harrington D.P. Revascularization for femoropopliteal disease. A decision and cost-effectiveness analysis. JAMA 274 (1995) 165-171
14. de Vries S.O., Visser K., de Vries J.A., Wong J.B., Donaldson M.C., and Hunink M.G. Intermittent claudication: cost-effectiveness of revascularization versus exercise therapy. Radiology 222 (2002) 25-36
15. Lee H.L., Mehta T., Ray B., Heng M.S., McCollum P.T., and Chetter I.C. A non-randomised controlled trial of the clinical and cost effectiveness of a supervised exercise programme for claudication. Eur J Vasc Endovasc Surg 33 (2007) 202-207
16. O'Hare A.M., Sidawy A.N., Feinglass J., Merine K.M., Daley J., Khuri S., Henderson W.G., and Johansen K.L. Influence of renal insufficiency on limb loss and mortality after initial lower extremity surgical revascularization. J Vasc Surg 39 (2004) 709-716
17. Brosi P., Baumgartner I., Silvestro A., Do D.D., Mahler F., Triller J., and Diehm N. Below- the-knee angioplasty in patients with end-stage renal disease. J Endovasc Ther 12 (2005) 704-713
18. Stoner M.C., deFreitas D.J., Phade S.V., Parker F.M., Bogey W.M., and Powell S. Mid-term results with laser atherectomy in the treatment of infrainguinal occlusive disease. J Vasc Surg 46 (2007) 289-295